Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

Arwa Z. Al-Riyami, Monika Hudoba, Sean Young, Donna Forrest

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)1788-1790
Number of pages3
JournalLeukemia and Lymphoma
Volume54
Issue number8
DOIs
Publication statusPublished - Aug 2013

    Fingerprint

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this